1. 南京中医药大学中医药文献研究所
2. 南京中医药大学基础医学院
3. 江苏省方剂研究重点实验室
纸质出版:2015
移动端阅览
[1]李筠,范欣生,钱大玮,陈菲,陈玉华.附子、半夏同方应用规律文献研究[J].中医杂志,2015,56(22):1961-1964.
LI Jun, FAN Xinsheng, QIAN Dawei, et al. Literatre Research on the Principles of Fuzi(Radix aconiti carmichaeli,附子) and Banxia(Pinellia ternate,半夏) Applied in One Prescription[J]. Journal of Traditional Chinese Medicine2015, 56(22): 1961-1964.
[1]李筠,范欣生,钱大玮,陈菲,陈玉华.附子、半夏同方应用规律文献研究[J].中医杂志,2015,56(22):1961-1964. DOI: 10.13288/j.11-2166/r.2015.22.020.
LI Jun, FAN Xinsheng, QIAN Dawei, et al. Literatre Research on the Principles of Fuzi(Radix aconiti carmichaeli,附子) and Banxia(Pinellia ternate,半夏) Applied in One Prescription[J]. Journal of Traditional Chinese Medicine2015, 56(22): 1961-1964. DOI: 10.13288/j.11-2166/r.2015.22.020.
目的探讨附子、半夏反药同方配伍的应用情况和配伍特点。方法收集中国知识资源总库(CNKI)、万方医学期刊全文库、维普中文科技期刊全文数据库中附子、半夏同方配伍应用的文献
建立数据库
提取纳入文献中病例数、治疗疾病、药物等信息
采用描述性分析对附子、半夏反药同方应用的疾病系统、主要病症进行统计
并对其同方配伍药对及核心药组进行关联规则分析。结果纳入文献共1295篇
涉及患者30042例。纳入文献中附子、半夏同方配伍临床主要应用于咳喘(176篇
占13.59%)、胸痹(86篇
占6.64%)、胃炎胃痛(77篇
占5.95%)
所治疗病症主要归属于消化系统(290篇
占22.39%)、心血管疾病(260篇
占20.07%)、呼吸系统(208篇
占16.06%);附子、半夏同方应用治疗疾病的以咳喘、慢性胃炎、胸痹为多见。关联分析显示
附子、半夏同方配伍的核心药物为甘草、茯苓、干姜、白术、桂枝、陈皮、党参、细辛等
核心药对为附子-半夏、附子-甘草、半夏-甘草、附子-干姜、半夏-干姜、半夏-白术等。3篇文献报道附子、半夏同方配伍有不良反应。结论附子、半夏反药同方配伍多治疗咳喘、慢性胃炎、胸痹等呼吸、消化系统及心血管疾病
其同方应用时多与补气、健脾、温中等药物配伍;二者配伍应谨慎使用。
Objective To explore the concerted application and characteristics of contrary herbal drugs Fuzi( Radix aconiti carmichaeli
附子) and Banxia( Pinellia ternate
半夏) applied in one prescription. Methods All published literature on Fuzi and Banxia applied in one prescription searched from China National Knowledge Infrastructure( CNKI)
Wan Fang Data and VIP Database was reviewed. Information in the collected literature
such as case number
diseases and herbs
was extracted to establish a database. Diseases and the relevant systems
as well as main symptoms treated with Fuzi and Banxia applied in one prescription were analyzied adopting descriptive analysis method. Drug pairs and core drug groups in the prescriptions with Fuzi and Banxia were analyzied with association rules technique. Results Totally 1295 papers were included in
with 30042 patients involved. In those literature Fuzi and Banxia were mainly prescribed in the same formular for cough and asthma( 176 papers
13. 59%)
chest bi( 86 papers
6. 64%)
and gastritis and stomachache( 77 papers
5. 95%). Diseases treated mainly belonged to digestive system conditions( 290 papers
22. 39%)
cardiovascular diseases( 260 papers
20. 07%) and respiratory diseases( 208 papers
16. 06%). Patients treated with Fuzi and Banxia commonly got cough and asthma
chronic gastritis and chest bi. Results of associated analysis showed that core herbs that applied together with Fuzi and Banxia in the same prescription were Gancao( Radix Glycyrrhizae
甘 草)
Fuling( Poria
茯 苓)
Ganjiang( Rhizoma Zingiberis
干姜)
Baizhu( Rhizoma Atractylodis Macrocephalae
白 术)
Guizhi( Ramulus Cinnamomi
桂 枝)
Chenpi( Pericarpium Citri Reticulatae
陈皮)
Dangshen( Radix Codonopsis
党参)
Xixin( Herba Asari
细辛).Core drug pairs were Fuzi and Banxia
Fuzi and Gancao
Banxia and Gancao
Fuzi and Ganjiang
Banxia and Ganjiang
Banxia and Baizhu. Three papers reported that there were side effects in the concerted application of Fuzi and Banxia in same prescriptions. Conclusion The concerted application of contrary herbal drugs Fuzi and Banxia are mostly for cough and asthma
chronic gastritis
chest bi and other respiratory
digestive and cardiovascular diseases.Herbs of invigorating Qi
strengthening spleen and warming the middle-jiao are often combined with Fuzi and Banxia.The concerted application of Fuzi and Banxia should be used cautiously.
0
浏览量
972
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号